Form 4: Vivani Medical Director Boosts Stake

Sentiment:

Insider Transaction Report


Vivani Medical's Director and 10% owner, Gregg Williams, significantly increased his beneficial ownership through two private stock purchases totaling over $1.98 million.

Better than expectedA significant insider, who is both a Director and a 10% owner, has made substantial purchases of the company's stock.The total investment of nearly $2 million indicates strong confidence from a key stakeholder.Insider buying often signals management's belief that the stock is undervalued or that positive developments are anticipated.

Summary

  • Gregg Williams, a Director and 10% owner of Vivani Medical, Inc. (VANI), reported two significant purchases of common stock.
  • On January 15, 2026, Williams acquired 1,473,214 shares at $1.12 per share, totaling $1,649,999.68. This purchase was part of a private sale agreement dated March 26, 2025.
  • On the same date, Williams purchased an additional 264,551 shares at $1.26 per share, amounting to $333,334.26. This transaction was under a private sale agreement dated August 11, 2025.
  • Following these transactions, Williams' total beneficial ownership, directly and indirectly, stands at 31,363,309 shares.
  • The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 8

Explanation: The significant insider buying by a director and 10% owner, totaling nearly $2 million, indicates strong confidence in the company's prospects. This is a very positive signal for investors.

Positives

  • A Director and 10% owner, Gregg Williams, made substantial purchases of Vivani Medical common stock, indicating confidence in the company's future.
  • Total insider purchases amounted to $1,983,333.94 across two transactions.
  • The transactions were executed under a Rule 10b5-1(c) plan, suggesting pre-planned investment decisions.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it primarily reports insider transactions.

Industry Context

This Form 4 filing primarily reports insider transactions and does not provide broader industry context or trends.

Related Party Transactions

  • Gregg Williams, a Director and 10% owner, purchased shares from the issuer in private sale transactions.
  • The purchases were made under Share Purchase Agreements dated March 26, 2025, and August 11, 2025.

Stakeholder Impact

  • Shareholders: May view the insider buying as a positive signal, potentially increasing confidence and demand for the stock.
  • Management/Employees: Could boost morale and reinforce belief in the company's direction.

Key Dates

DateDescription
03/25/2025Last reported sale price of Vivani Medical common stock on Nasdaq ($1.12) prior to the March 26, 2025 agreement.
03/26/2025Date of Share Purchase Agreement for the acquisition of 1,473,214 shares.
08/10/2025Last reported sale price of Vivani Medical common stock on Nasdaq ($1.26) prior to the August 11, 2025 agreement.
08/11/2025Date of Share Purchase Agreement for the acquisition of 264,551 shares.
01/15/2026Transaction date for both common stock purchases by Gregg Williams.
01/20/2026Date the Form 4 was signed and filed.

Recommendation

buy

The substantial insider purchases by a Director and 10% owner, Gregg Williams, totaling nearly $2 million, signal strong conviction in Vivani Medical's future performance. Such significant insider buying often precedes positive company developments or indicates a belief that the stock is currently undervalued, making it an attractive entry point for investors.

Keywords

Vivani Medical, VANI, Gregg Williams, Insider Buying, Form 4, Stock Purchase, Beneficial Ownership, Director, 10% Owner, Private Sale, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.